What is Trial-to-Paid Conversion?
Trial-to-Paid Conversion is the percentage of trial users that become paying customers. It divides the number of trials that converted to paid by the total number of trials that reached a decision point — converted or expired — in the same period, then multiplies by 100. Trial-to-Paid measures onboarding quality, product-market fit, and the effectiveness of your trial experience.
For SaaS with a 14-day trial, 15–25% is healthy. Below 10% suggests the trial isn’t demonstrating enough value. Above 30% is strong — your trial experience is effectively converting prospects into paying customers.
Unlike revenue metrics like MRR, Trial-to-Paid sits at the top of your revenue funnel. Every percentage point of improvement translates directly to more new paying customers, more new business MRR, and faster growth.
The Trial-to-Paid formula
Worked example
September 2026: 20 trials reached their decision point (trial period ended).
| Outcome | Count | Details |
|---|---|---|
| Converted to paid | 15 | 12 still active, 3 canceled after 1+ billing cycle |
| Expired / canceled | 5 | Never charged |
| Still in trial (excluded) | 30 | Not yet at decision point |
Three out of four trials that reached a decision point became paying customers. The 3 customers who converted and later canceled still count — the metric measures the trial experience, not long-term retention. The 30 active trials are excluded because they haven’t ended yet.
The revenue impact
If your ARPA is $50/month and you improve conversion from 15% to 25%, each cohort of 100 ended trials produces 10 additional paying customers — $500/month in new MRR, or $6,000/year. The dollar impact scales with trial volume and ARPA.
How it’s computed
North Metric uses a Trial-End Cohort method — trials are grouped by when they ended (came up for decision), not when they started. The conversion check uses billing cycle behavior, not just subscription status.
What counts as “converted”
A trial counts as converted if the customer paid for at least one billing cycle after the trial ended. This catches short-lived conversions — a customer who converts, pays for one month, then cancels is still a successful conversion. The question is “did the trial lead to a sale?” not “did the customer stay forever?” Retention after conversion is tracked by Customer Churn Rate.
Why “trials ended” not “trials started”
A trial-end cohort gives you a final number when the month closes. A trial-start cohort updates retroactively as late conversions happen — May’s rate changes in July when a lingering trial finally converts. For founders checking metrics daily, a retroactively-changing number erodes trust. Low trial volume (5–20/month) makes retroactive swings even more pronounced.
Cross-validation
Trial-to-Paid has been validated against Stripe raw subscription data. All trial subscriptions were individually verified — each conversion confirmed by checking billing history after the trial end date. Results match across multiple months once the billing-cycle check is applied.
Trial-End vs Trial-Start cohorts
The biggest source of difference between trial conversion tools is the cohort method. North Metric uses trial-end; ChartMogul uses trial-start. Both are valid — they answer slightly different questions.
| Trial-End (North Metric) | Trial-Start (ChartMogul) | |
|---|---|---|
| Groups trials by | When the trial period ended | When the trial started |
| The question it answers | "Of trials that ended this month, how many converted?" | "Of trials that started this month, how many eventually converted?" |
| Retroactive changes | Never — number is final when the month closes | Yes — rate updates as late conversions happen weeks later |
| Current month accuracy | Accurate for ended trials; active trials excluded | Looks artificially low (most trials haven't ended yet) |
| Best for | Daily tracking, actionable reporting, low-volume accounts | Cohort analysis, long-term trend studies, high-volume accounts |
Common Trial-to-Paid mistakes
- Including active trials in the denominator. Counting trials that haven’t ended yet dilutes the conversion rate. If 20 trials ended (15 converted) but 30 are still active, including them drops the rate from 75% to 30%. Only count trials that reached a decision point.
- Using status instead of billing behavior. A trial that converts and later cancels shows status “canceled” — but the customer did pay. Checking only for “active” status misses short-lived conversions and understates your true conversion rate.
- Comparing trial-end and trial-start rates directly. A 25% trial-end rate and a 15% trial-start rate for the same month aren’t comparable — they measure different cohorts. Understand which method your tools use before comparing numbers.
- Ignoring trial volume alongside conversion rate. A 50% conversion rate from 4 trials is noisier than a 15% rate from 200 trials. Low-volume accounts should track the rate alongside absolute counts and use trailing averages for trend analysis.
- Treating all trials as equal. A $29/mo trial converting is different from a $500/mo trial converting. Consider segmenting Trial-to-Paid by plan tier for actionable insights about which products convert best.
SaaS Trial-to-Paid benchmarks
Trial-to-Paid benchmarks vary more by business model than company size. Product-led growth companies with self-serve trials typically see 8–25%. Sales-assisted trials with demos and onboarding reach 18–38%. Higher is better — a rising conversion rate means your trial experience is improving.
| Stage · MRR | Bottom 25% | Median | Top 25% |
|---|---|---|---|
| Seed · < $10K | 3.0% | 8.0% | 18.0% |
| Early · $10K – $50K | 5.0% | 12.0% | 25.0% |
| Growth · $50K – $100K | 8.0% | 15.0% | 28.0% |
| Scale · $100K – $500K | 10.0% | 18.0% | 32.0% |
| Enterprise · $500K+ | 12.0% | 22.0% | 38.0% |
Frequently asked questions
What is a good Trial-to-Paid conversion rate for SaaS?
For SaaS with a 14-day trial, 15–25% is healthy. Below 10% suggests the trial isn’t demonstrating enough value — review your onboarding flow. Above 30% is strong. Opt-in trials (credit card required) typically convert at 40–60% but attract fewer signups. The median across all stages ranges from 8% (Seed) to 22% (Enterprise).
Should I use trial-end or trial-start cohorts?
Trial-end gives you a final, non-retroactive number each month — ideal for daily monitoring and board reporting. Trial-start gives you cohort analysis that tracks each batch over time — better for long-term studies. Both produce the same rate when trial lengths are fixed; they diverge with variable-length trials.
Why does a canceled subscription count as a conversion?
Because the customer paid. If someone completes a trial, pays for one billing cycle, then cancels, the trial successfully converted them into a paying customer. Post-conversion retention is a separate question tracked by churn rate. Excluding these conversions understates your trial’s effectiveness and conflates two distinct problems.
How do I improve my Trial-to-Paid conversion rate?
Focus on time-to-value during the trial window. Identify the activation event that correlates with conversion — the moment the user experiences the product’s core value. Then optimize onboarding to reach that event within the first 1–3 days. Targeted emails and in-app guidance for inactive trial users can recover 5–10 percentage points.
Why is my Trial-to-Paid rate different from ChartMogul?
ChartMogul groups trials by start date; North Metric groups by end date. With a 14-day trial, conversions appear one period later in North Metric. ChartMogul’s current-month rate also looks lower because most trials started this month haven’t ended yet. Expect the two tools to converge over time but diverge on any single month.
From metric to action
North Metric ranks your paying Stripe customers by money at risk, so you see who is likely to leave before this number moves. See how churn prediction works.